Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Liver mitochondrial enzyme system in the dynamics of experimental leukemia

Gulmira Kasymova, Ulugbek Zaribbaev

. 2012 ; 2012 (4) : 21-24.

Language English Country Czech Republic Media elektronický zdroj

In rats with leukemia activity of liver mitochondrial enzymes are decreased at 6 months. Later, we noted compensatory activation of complexes II and III of the respiratory chain and transition to decompensation stage by final deadline. The activity of complex IV of the respiratory chain remains high. These changes result from increased lipid peroxidation and decreased activity of antioxidant protection enzymes.

Liver mitochondrial enzyme system in the dynamics of experimental leukemia [elektronický zdroj] /

References provided by Crossref.org

Bibliography, etc.

Literatura

000      
00000naa a2200000 a 4500
001      
bmc14046152
003      
CZ-PrNML
005      
20141105091854.0
007      
cr|cn|
008      
140215s2012 xr fs 000 0eng||
009      
eAR
024    7_
$a 10.12955/emhpj.v4i0.361 $2 doi
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Kasymova, Gulmira $u Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan
245    10
$a Liver mitochondrial enzyme system in the dynamics of experimental leukemia $h [elektronický zdroj] / $c Gulmira Kasymova, Ulugbek Zaribbaev
504    __
$a Literatura
520    9_
$a In rats with leukemia activity of liver mitochondrial enzymes are decreased at 6 months. Later, we noted compensatory activation of complexes II and III of the respiratory chain and transition to decompensation stage by final deadline. The activity of complex IV of the respiratory chain remains high. These changes result from increased lipid peroxidation and decreased activity of antioxidant protection enzymes.
650    12
$a modely nemocí na zvířatech $7 D004195
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a výzkumný projekt $7 D012107
650    _2
$a leukemie $x chemicky indukované $7 D007938
650    _2
$a injekce subkutánní $7 D007279
650    _2
$a nebezpečné látky $x škodlivé účinky $7 D015386
650    12
$a játra $x imunologie $x účinky léků $7 D008099
650    12
$a jaterní mitochondrie $x enzymologie $x imunologie $x účinky léků $7 D008930
650    _2
$a časové faktory $7 D013997
650    _2
$a zvířata $7 D000818
700    1_
$a Zaribbaev, Ulugbek $u Research Institute of Hematology and Blood Transfusion, Tashkent, Uzbekistan
773    0_
$t European medical, health and pharmaceutical journal $x 1804-5804 $g Roč. 2012, č. 4 (2012), s. 21-24 $w MED00177703
856    41
$u https://ojs.journals.cz/index.php/EMHPJ/issue/view/45 $y plný text volně přístupný
910    __
$a ABA008 $y 4 $z 0
990    __
$a 20140213090030 $b ABA008
991    __
$a 20141105091902 $b ABA008
999    __
$a ok $b bmc $g 1013097 $s 844688
BAS    __
$a 3 $a 4 $a PRD
BMC    __
$a 2012 $b 2012 $c 4 $d 21-24 $i 1804-5804 $m European Medical, Health and Pharmaceutical Journal $n Eur. Med. Health Pharm. J. $x MED00177703
LZP    __
$c NLK183 $d 20141105 $a NLK 2014-12/vt

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...